Therapeutic Potential of Chemically Modified miR-489 in Triple-Negative Breast Cancers

Triple-negative breast cancers (TNBCs) lack ER, PR and her2 receptors that are targets of common breast cancer therapies with poor prognosis due to their high rates of metastasis and chemoresistance. Based on our previous studies that epigenetic silencing of a potential metastasis suppressor, arrest...

Descripción completa

Detalles Bibliográficos
Autores principales: Soung, Young Hwa, Chung, Heesung, Yan, Cecilia, Fesler, Andrew, Kim, Hyungjin, Oh, Eok-Soo, Ju, Jingfang, Chung, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463492/
https://www.ncbi.nlm.nih.gov/pubmed/32784600
http://dx.doi.org/10.3390/cancers12082209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7463492/
https://www.ncbi.nlm.nih.gov/pubmed/32784600
http://dx.doi.org/10.3390/cancers12082209

Ejemplares similares